Tenon Medical (TNON) Director Richard Ferrari Receives 64,479 Shares

What Happened
Richard Ferrari, a director of Tenon Medical, converted 64,479 restricted stock units (RSUs) into 64,479 shares of common stock on July 31, 2026. The Form 4 shows an exercise/conversion of a derivative (transaction code M) with acquisition and corresponding disposition entries at $0 per share — total recorded value $0. This was a vesting/settlement of an award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-31 (filed on 2026-08-04). Filing does not indicate a late report.
• Reported entries: Acquired 64,479 shares @ $0.00 (M); Disposed 64,479 shares @ $0.00 (M) — the disposition entry reflects conversion of the derivative into shares.
• Price/Value: $0.00 per share; total recorded value $0.
• Shares owned after transaction: not specified in the filing.
• Footnotes: F1 — conversion of 64,479 RSUs granted Oct 13, 2025; F2 — each RSU equals a contingent right to one share.
• Accession: 0001213900-26-085243 (Form 4 for reference).

Context
This was a routine settlement of previously granted RSUs (derivative conversion), not a market purchase or a sale. Because no shares were sold immediately, the transaction does not by itself indicate buying or selling sentiment. Transaction code M denotes exercise/conversion of a derivative instrument (RSUs converted into common stock).